These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 1846331)

  • 21. Comparisons of beta-adrenergic blocking properties of S- and R-timolol in humans.
    Rotmensch HH; Vlasses PH; Feinberg JA; Abrams WB; Ferguson RK
    J Clin Pharmacol; 1993 Jun; 33(6):544-8. PubMed ID: 8103526
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Beta-adrenoceptors mediate inhibition of lipolysis in adipocytes of tilapia (Oreochromis mossambicus).
    Vianen GJ; Obels PP; van den Thillart GE; Zaagsma J
    Am J Physiol Endocrinol Metab; 2002 Feb; 282(2):E318-25. PubMed ID: 11788363
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of methods to assess cyclic AMP turnover under conditions of agonist stimulation in 1321N1 astrocytoma cells.
    Morgan AJ; Murray KJ; Challiss RA
    Biochem Soc Trans; 1992 May; 20(2):136S. PubMed ID: 1327900
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of isoproterenol on the plasma C-peptide and insulin levels in humans.
    Górski J; Holm G; Krotkiewski M
    Horm Res; 1989; 31(4):175-9. PubMed ID: 2571555
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation and bioelectrical effects of cyclic adenosine monophosphate production in the ciliary epithelial bilayer.
    Horio B; Sears M; Mead A; Matsui H; Bausher L
    Invest Ophthalmol Vis Sci; 1996 Mar; 37(4):607-12. PubMed ID: 8595960
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of cardiac effects of timolol and propranolol.
    Achong MR; Piafsky KM; Ogilvie RI
    Clin Pharmacol Ther; 1975 Sep; 18(3):278-86. PubMed ID: 1100298
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of catecholamines and adrenergic-blocking agents on plasma and urinary cyclic nucleotides in man.
    Ball JH; Kaminsky NI; Hardman JG; Broadus AE; Sutherland EW; Liddle GW
    J Clin Invest; 1972 Aug; 51(8):2124-9. PubMed ID: 4403383
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systemic effects of three beta-blocker eyedrops: comparison in healthy volunteers of beta 1- and beta 2-adrenoreceptor inhibition.
    Le Jeunne C; Munera Y; Hugues FC
    Clin Pharmacol Ther; 1990 May; 47(5):578-83. PubMed ID: 1971539
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence for a synergistic interaction between isoprenaline and timolol on intraocular pressure in conscious rabbits.
    Santafe J; Segarra J; Garrido M; Pablo V; Martinez de Ibarreta MJ
    Gen Pharmacol; 1993 Mar; 24(2):471-8. PubMed ID: 8387057
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinically relevant concentrations of olprinone reverse attenuating effect of propofol on isoproterenol-induced cyclic adenosine monophosphate accumulation in cardiomyocytes.
    Kurokawa H; Matsunaga A; Tanaka H; Hamada H; Kawamoto M; Yuge O
    Hiroshima J Med Sci; 2008 Mar; 57(1):1-6. PubMed ID: 18578361
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of furosemide on plasma concentration and beta-blockade by propranolol.
    Chiariello M; Volpe M; Rengo F; Trimarco B; Violini R; Ricciardelli B; Condorelli M
    Clin Pharmacol Ther; 1979 Oct; 26(4):433-6. PubMed ID: 226305
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Beta-adrenergic receptor activation inhibits keratinocyte migration via a cyclic adenosine monophosphate-independent mechanism.
    Chen J; Hoffman BB; Isseroff RR
    J Invest Dermatol; 2002 Dec; 119(6):1261-8. PubMed ID: 12485426
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Systemic bioavailability and cardiopulmonary effects of 0.5% timolol eyedrops.
    Korte JM; Kaila T; Saari KM
    Graefes Arch Clin Exp Ophthalmol; 2002 Jun; 240(6):430-5. PubMed ID: 12107508
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacological effects of topical timolol in the rabbit eye.
    Bartels SP; Roth HO; Jumblatt MM; Neufeld AH
    Invest Ophthalmol Vis Sci; 1980 Oct; 19(10):1189-97. PubMed ID: 6106643
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Paroxetine markedly increases plasma concentrations of ophthalmic timolol; CYP2D6 inhibitors may increase the risk of cardiovascular adverse effects of 0.5% timolol eye drops.
    Mäenpää J; Volotinen-Maja M; Kautiainen H; Neuvonen M; Niemi M; Neuvonen PJ; Backman JT
    Drug Metab Dispos; 2014 Dec; 42(12):2068-76. PubMed ID: 25261563
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bronchial beta-adrenoceptor blockade following eyedrops of timolol and its isomer L-714,465 in normal subjects.
    Richards R; Tattersfield AE
    Br J Clin Pharmacol; 1985 Nov; 20(5):459-62. PubMed ID: 2866789
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Norepinephrine- and isoproterenol- induced changes in cardiac contractility and cyclic adenosine 3':5' -monophosphate levels during early development of the embryonic chick.
    Polson JB; Goldberg ND; Shideman FE
    J Pharmacol Exp Ther; 1977 Mar; 200(3):630-7. PubMed ID: 191591
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Topical norepinephrine, isoproterenol, terbutaline, forskolin and 8-bromo cyclic AMP increase lens equatorial current.
    Walsh SP; Patterson JW
    Exp Eye Res; 1993 Mar; 56(3):267-73. PubMed ID: 8472783
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of beta-adrenergic blockade on plasma cyclic AMP and blood sugar responses to glucagon and isoproterenol in man.
    Messerli FH; Kuchel O; Tolis G; Hamet P; Fraysse J; Genest J
    Int J Clin Pharmacol Biopharm; 1976 Oct; 14(3):189-94. PubMed ID: 187546
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Beta 1- and beta 2-adrenoceptor subtypes in canine intrathoracic efferent sympathetic nervous system regulating the heart.
    Watson-Wright W; Boudreau G; Cardinal R; Armour JA
    Am J Physiol; 1991 Nov; 261(5 Pt 2):R1269-75. PubMed ID: 1683175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.